The in vivo kinetic behavior of [ II C]flumazenil ([llCjFMZ), a non-subtype-specific central benzodiaze pine antagonist, is characterized using compartmental analysis with the aim of producing an optimized data ac quisition protocol and tracer kinetic model configuration for the assessment of [llCjFMZ binding to benzodiaze pine receptors (BZRs) in human brain. The approach pre sented is simple, requiring only a single radioligand injec tion. Dynamic positron emission tomography data were acquired on 18 normal volunteers using a 60-to 90-min sequence of scans and were analyzed with model config urations that included a three-compartment, four parameter model, a three-compartment, three-parameter model, with a fixed value for free plus nonspecific bind ing; and a two-compartment, two-parameter model. Sta-
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The in vivo kinetic behavior of [ II C]flumazenil ([llCjFMZ) , a non-subtype-specific central benzodiaze pine antagonist, is characterized using compartmental analysis with the aim of producing an optimized data ac quisition protocol and tracer kinetic model configuration for the assessment of [llCjFMZ binding to benzodiaze pine receptors (BZRs) in human brain. The approach pre sented is simple, requiring only a single radioligand injec tion. Dynamic positron emission tomography data were acquired on 18 normal volunteers using a 60-to 90-min sequence of scans and were analyzed with model config urations that included a three-compartment, four parameter model, a three-compartment, three-parameter model, with a fixed value for free plus nonspecific bind ing; and a two-compartment, two-parameter model. Sta- The assessment of neurotransmitter receptor density in living persons is now possible through the use of radiolabeled ligands and dynamic positron emission tomography (PET) . The purpose of this study is to characterize the in vivo kinetic behavior of e1C]flumazenil ([llC]FMZ). [llC] FMZ is a non subtype-specific central benzodiazepine antagonist with the potential of providing a tool for estimating benzodiazepine receptor (BZR) density. PET stud ies using [llC] FMZ have been reported previously in humans (Persson et aI., 1985 (Persson et aI., , 1989 tistical analysis indicated that a four-parameter model did not yield significantly better fits than a three-parameter model. Goodness of fit was improved for three-versus two-parameter configurations in regions with low recep tor density, but not in regions with moderate to high re ceptor density. Thus, a two-compartment, two-parameter configuration was found to adequately describe the ki netic behavior of [ II CjFMZ in human brain, with stable estimates of the model parameters obtainable from as lit tle as 20-30 min of data. Pixel-by-pixel analysis yields functional images of transport rate (K1) and ligand distri bution volume (DV"), and thus provides independent es timates of ligand delivery and BZR binding. Key Words: Benzodiazepine receptors-e lCjFlumazenil-Positron emission tomography-Tracer kinetics. aI., 1986 Pappata et aI., 1988; Blomqvist et aI., 1990; Price et aI., 1990) . Analysis of the data in the first five of these studies focused on the regional concentration of e lC]FMZ in brain at various times following injection and on the effects that various competitors for BZR binding sites have on the level of e lC]FMZ uptake. The methods employed fall into the general category of equilibrium techniques. These approaches assume that all model compart ments reach equilibrium rapidly and that a single scan, initiated after equilibrium is reached, can pro vide an estimate of receptor occupancy. A region that is assumed to have little or no specific binding is then used to estimate the free and nonspecifically bound component of the radiotracer concentration. The last two studies report kinetic analyses, with the work of Blomqvist et aI. (1990) reporting a method using multiple radioligand administrations without arterial sampling and employing some of the assumptions of an equilibrium approach. Price et al. (1990) report a dynamic approach using two separate administrations of e IC]FMZ and arterial sampling to estimate receptor density and binding affinity.
We present here an alternative approach requir ing only a single radioligand injection, which allows for separation of the radiotracer delivery from the binding processes and provides functional images of model parameters representing ligand transport rate and distribution of volume. Unlike equilibrium ap proaches, this technique does not require that equi librium conditions be achieved, but relies upon a measured arterial input function to allow compart mental analysis. Use of a single administration shortens the study and simplifies the protocol con siderably, but assumes that the estimate of a com bined receptor parameter reflecting both receptor density and ligand affinity is sufficient.
We present here kinetic analysis using two-and three-compartment model configurations contain ing two, three, or four rate parameters. We use these results to produce an optimized acquisition and analysis protocol for use with [IIC]FMZ and PET.
THEORY
The analysis of e IC]FMZ distribution begins with a kinetic model depicted in Fig. 1 . The model con sists of one blood compartment, representing free ligand in arterial plasma (Cp), and three tissue com partments, representing free ligand in tissue (C F ), ligand bound to nonspecific sites (CNS)' and ligand bound to specific sites (Cs)' The six rate parameters describe exchange across the blood-brain barrier, binding and release from the sites in the nonspecif ically bound compartment, and binding and release from sites in the specifically bound compartment. Some kinetic parameters require further definition as follows: K I = f Eo =f(1 -e-P S1f ) (ml g-I min-I)
wherefis mass specific blood flow (ml g-I min-I),
Eo is the single-pass extraction fraction of ligand into brain, PS is the permeability-surface area product (ml g -I min -I), D V F is the equilibrium dis tribution volume of ligand in the free tissue com partment (ml g-l), ko n is the bimolecular associa tion rate between ligand and receptor (g pmol-I min -I), Bmax' is the receptor density or concentra tion of "unoccupied" receptors (pmol g-I), koff is the dissociation rate of ligand from the receptor complex (min -I), and Kd is the equilibrium ligand binding constant for the specific receptor site (pmol g-l or nM). The ratio of receptor-related parame ters Bmax' and Kd has been previously referred to as the "binding potential" by Mintun et al. (1984) . This model is too complex for practical imple mentation with current PET studies when only one tracer dose is administered. The statistical quality of the PET data and the insensitivity of the model configurations to changes in individual parameters do not allow adequate estimation of all six rate con stants. Figure 2 depicts a simplified configuration where the free and nonspecifically bound tissue compartments are assumed to equilibrate rapidly. For this assumption to be valid, the values of the rate constants ks and k6 must be high relative to K I and k2 and rapid compared to the scanning inter vals. With this simplification, there now exist only C s FIG. 1. Four-compartment kinetic model. This configuration represents the most general for mulation considered and is the starting point for subsequent model simplifications. It includes compartments for plasma (Cp), free ligand in tis sue (CF), and nonspecific (CNS) and specific (Cs) binding. Tracer exchange is described by six rate constants, K1-ks. BBB, blood-brain barrier. This configuration simplifies the model de picted in Fig. 1 by combining free and non specific pools into a single compartment (CF+NS) and assumes that rate constants k5 and k6 are rapid compared to blood-brain barrier (BBB) transport rates.
Cp
two tissue compartments and four rate constants. However, new rate constant descriptions are nec essary to account for the changes in the compart ment definitions:
where DV' = DV F (1 + kslk6) = DV F +NS and is equal to the summed distribution volumes of the free and nonspecifically bound compartments. The quantity (1 + kslk6) reflects the apparent increase in size of the binding precursor compartment. Thus, the term 11(1 + kslk6) describes the fraction of ra diolabel available either for transport back to plasma or binding to specific receptor sites and is equivalent to the term f2 used by Mintun et al. (1984) and others. The solution to this model form is given by
and where ® represents the mathematical opera tion of convolution.
If, in addition, the binding and release of ligand from the specific receptor compartment are rapid compared to the transport parameters Kj and k2', the model can be further reduced to two compart ments where a single tissue compartment contains free, nonspecific ally bound, and specifically bound ligand, as shown in Fig. 3 . The kinetic parameters of this simplified model are described as follows:
... 
Cs
where DV" is the apparent distribution volume of the summed tissue compartments. The solution equation to this model form is given by
Integration of Eq. 6 over the duration of each scan provides the appropriate mathematical formulation required for the compartmental analysis. Since k3' and Bm ax ' are no longer isolated model parameters,
receptor information in this model configuration is represented only by D V". As the ratio of association to dissociation rate (k3Ik4) becomes progressively higher, the specific distribution volume term domi nates and DV" yields a progressively better estimate tissue compartment now includes free, nonspecific, and spe cific compartments and assumes that all tissue pools equil ibrate rapidly with respect to blood-brain barrier (BBB) transport rates. of Bmax'. By assuming values for the free and non specific distribution volumes, the ratio Bmax'IKd can be calculated directly from DV".
METHODS
Six young normal volunteers, 21-32 years of age, were studied following administration of 35-50 mCi of [IlC]FMZ. No-carrier-added [ II C]FMZ (500-2,000 Ci/ mmol) was prepared by modifications of literature meth ods (Ehrin et aI., 1984; Maziere et aI., 1984) . A sequence of 18 PET scans was acquired on a Siemens/Cn 93 1/ 08-12 scanner for 90 min post injection. Calculated atten uation was performed on all images. Blood samples were withdrawn via a radial artery catheter as rapidly as pos sible for the first 2 min of the scan and then at progres sively longer intervals for the remainder of the study. Plasma was separated from red cells by centrifugation and counted in an NaI well counter. The plasma radioac tivity time course was corrected for radiolabeled metab olites using a rapid Sep-Pak C I 8 cartridge chromato graphic technique (Frey et aI., 199 1) . The samples at I and 2 min and all subsequent samples (13 in all) were analyzed for metabolites. Metabolite fractions of other samples prior to 2 min post injection were estimated by linear interpolation. The fraction of authentic [IIC]FMZ in plasma decreased rapidly following administration, typically reaching 50% by 10 min, 30-35% by 30 min, then becoming relatively constant at 25-30% by 90 min post injection.
Owing to the relatively long scan duration, we em ployed a method using radioactive fiducial markers to correct for any patient motion occurring throughout the study. Molecular sieve beads (1-2 mm in diameter) were placed at various points on the patient's scalp prior to the study. Approximately I ,.d of the ligand preparation was pipetted onto each bead at a concentration of 0.25 J.lCi/mCi [IlC]FMZ injected. Thus, for a 40-mCi injection, each bead was labeled with � 10 J.lCi of I I C. Following reconstruction of the dynamic PET sequence, each bead was marked with a cursor in a single frame and the (x.Y.z) coordinates calculated based on the radioactivity distri bution in the vicinity of the beads. This frame defined a standard or base orientation. An automated routine lo cated and calculated the (x,Y.z) coordinates for each bead in the other 17 frames. These frames were then realigned to the orientation of the base frame. This method corrects for the three translational and three rotational degrees of freedom, and realigns image sets to within 1 mm and 10, respectively. Correction for motion was necessary in nearly half the SUbjects.
After appropriate registration of the image sequences, regions of interest (ROIs) were drawn on the base frame and applied to all other frames, thus generating time activity curves for the different brain structures. Regions analyzed included cerebral cortex (frontal and occipital), thalamus, caudate nucleus, putamen, cerebellar hemi spheres, and pons. Different model configurations were implemented for analysis of the FMZ kinetics in these time-activity sequences. The most complex model em ployed was the three-compartment, four-parameter model of Fig. 2 , fitting for transport (K I ), the free + non specific distribution volume (DV'), and the binding and dissociation rate constants (k3' and k4). A second config- 1991 uration tested was a three-compartment, three-parameter model, fitting only K I , k3', and k4, while using an assumed value for DV' assessed on an individual basis from the four-parameter fit to the pons. In the analysis of the pons, the assumption is made that the level specific binding is negligible; thus, the second tissue compartment of the three-compartment model is assumed to reflect nonspe cific instead of specific binding, and the rate constants estimated in the pons are K I , kz, ks, and k6, as seen in Fig.   1 . Finally, the two-compartment, two-parameter model of Fig. 3 was evaluated, fitting for K I and the total ligand distribution volume (DV").
Parameters were estimated for each configuration by standard nonlinear least-squares analysis using the Mar quardt algorithm (Bevington, 1969) with constraints re stricting parameters to positive values. Each model con figuration evaluated was implemented to account for ef fects of a cerebral blood volume (CBV) component in the measured PET data and for the time offset or shift be tween the plasma input function measured from the radial artery and the brain radioactivity time course measured by PET. The time offset was estimated by fitting the en tire slice for five different brain levels to a three compartment, four-parameter model using the entire 90min data set and assuming a whole-slice CBV of 0.035 ml g -I (3.5%). In all subsequent fits, the value for the offset was fixed to the average value estimated from the five levels. Next, for each ROI analyzed, the local value of CBV was estimated using this average time offset while simultaneously estimating K1, k2, and CBV from a two compartment model. Only the first 10 min of data was used to isolate blood volume effects as much as possible. This CBV value was then used as a fixed value when performing fits with all other model configurations. Thus, each subject had a single estimate of the time offset (used for all regions), while each region had a separate estimate of CBV. Even though rate constant estimates proved to be fairly insensitive to CBV and time shift, inclusion of both parameters in the model should reduce the bias in K I caused by their effects on the early data. Furthermore, fixing these parameters when applying the various mod els, instead of estimating them for each fit, ensures that comparisons of parameter estimates from the different model configurations are valid.
In addition, a two-parameter pixel-by-pixel weighted integral analysis (Alpert et aI., 1984) was performed, omitting the first 30 s of scan data from the calculations to reduce CBV effects on the estimated parameters (Koeppe et aI., 1987) . This approach produced functional images of ligand delivery (K I ) and binding (DV").
Parameter estimates were obtained for each model con figuration using intervals of data ranging from only the first 10 min following FMZ injection to the entire 90-min sequence. These tests provide measures of parameter identifiability versus study length, as indicated by the variability in the parameter estimates, and of the ability of each model configuration to describe the temporal behav ior of the ligand, as indicated by the stability of mean parameter estimates.
After detailed analysis of the data from the initial 6 subjects, an additional 12 young normal volunteers, aged 21-32 years, were studied with an abbreviated protocol. A sequence of 15 PET scans was acquired for 60 min following administration of 20-25 mCi of [II C]FMZ. Para metric images of ligand transport rate and distribution volume were calculated using the pixel-by-pixel weighted integral approach in the same manner as for the first six subjects.
RESULTS
In Table 1 results from least-squares fits to the PET data are shown for two-, three-, and four parameter model configurations. The entire 90-min data sequence was used in these fits. Table values give the mean and percentage coefficient of varia tion (COY; 100 x SD/mean) of each parameter for the first six volunteers. The mean reduced (x 2 )-values (sum of the squared discrepancies be tween data and model predictions divided by the number of degrees of freedom) for fits to the re gional time-activity curves are reported for the dif ferent model configurations. The k3 values reported are calculated from the k3' estimates by the relation ship k3' = k3/(l + k5Ik6)' where k5 and k6 come from the four-parameter fit to the pons, as described in Methods. Also presented for the three-and four parameter configurations are the k31k4 ratios, which provide estimates of the "binding potential",
Bma x'IKd '
Parameter estimates as a function of the duration of data used in the fits are shown in Figs. 4 and 5. Estimations were performed using as little as the first 10 min of data following injection to the entire 90-min sequence. Figure 4 shows estimates of ligand delivery (KI) for both a two-parameter model configuration (top) and a three-parameter configu ration (bottom). Figure 5 shows estimates of the receptor-related parameters, D V" for the two parameter fit (top), and k3 (center) and k4 (bottom) for a three-parameter fit. Shown are the means ± SEM for the pons, thalamus, and frontal cortex of the initial six subjects. In Table 2 is a comparison of K1 and DV7I esti mates from nonlinear least-squares analysis of large regions (accounting for time shift and CBY) and pixel-by-pixel analysis (assuming a fixed time shift of 6 s for all subjects and accounting for CBY ef fects only by omission of the first 30 s of data) for the first group of six volunteers. Results are also given for KI and DV" estimates from the pixel by-pixel approach for the second group of 12 sub jects. Figure 6 shows the relationship, across all re- Reported are mean and percentage coefficient of variation (% COV = 100 x SD/mean) for parameter estimates from two-, three-, and four-parameter model configurations. For fits in the pons using the three-and four-parameter models, the second tissue compartment is assumed to reflect nonspecific instead of specific binding. Thus, the parameters k3 and k4 are interpreted as k5 and k6• Values for KI are given in ml g-I min -I for k3 and k4 in min -I , for DV' and DV' in ml g-I , for X 2 mean reduced, X 2 for the fits. Shown are parameter estimates from least-squares fits using data from 10 to 90 min post injection.
gions, between the estimate of Bmax'IKd from a three-compartment, three-parameter analysis and the estimate of DV" from the two-compartment pixel-by-pixel weighted integral analysis for the six subjects. The correlation across all six subjects is 0.955, but correlations within any single individual are much higher (r = 0.989-0.996), reflecting the variability in the estimates of free and nonspecific distribution volumes across subjects.
DISCUSSION
PET using radiolabeled neuroreceptor ligands has recently begun to play an important role in the in vivo assessment of neurotransmitter function in the normal and diseased human brain. However, inter pretation of the data generated by many radioli gands requires a more sophisticated kinetic analysis J Cereb Blood Flow Metab, Vol. 11, No.5, 1991 than do data from earlier PET procedures, such as those involving C 8 F]fluorodeoxyglucose or e 5 0] H20. To extract reliable, accurate information from the data, any model configuration proposed for a new radio ligand must be evaluated in detail. If a model configuration is overly complex, the vari ances in the parameter estimates may be prohibi tively high and the reliability of the information ob tained would be poor. On the other hand, oversim plified model configurations may result in highly biased and inaccurate parameter estimates. There fore, application of a ligand without proper evalua tion of the proposed analysis could lead to errone ous interpretations.
We present here a compartmental analysis of the in vivo kinetics of [IIC]FMZ, a non-subtype specific central benzodiazepine antagonist, using model configurations involving either two or three compartments (Figs. 2 and 3 ) and two to four rate parameters. Owing to the rapid rate of binding and release from receptors (Persson et aI., 1985; Pap pata et aI., 1988; Shinotoh et aI., 1989) , consider ation of model configurations with this range of complexity appears appropriate. Previous ap proaches relied upon the rapid rate of equilibration to produce images of radioactivity concentration that were roughly proportional to receptor density. Analysis of the temporal behavior of the radioligand did not include compartmental modeling, but was limited to basic measures such as tissue radioactiv ity or percentage injected dose as functions of time. Instead, these previous works focused on the dem onstration of the specific binding of C lC]FMZ to central BZRs through the use of receptor blocking or competition experiments. More recent work em ploying kinetic analysis has been described for both a pseudo-equilibrium method without arterial sam pling (Blomqvist et aI., 1990 ) and a dynamic ap proach using compartmental analysis (Price et aI., 1990) . Both approaches, however, use multiple ra dioligand administrations to obtain separate esti mates of Bmax' and Kd. We propose here that a sin gle administration procedure, with appropriate ki netic analysis, can yield reliable receptor density information from a short simple scanning protocol that may be used on patients that cannot tolerate long imaging procedures.
The relative performance of the two-, three-, and four-parameter model configurations can be evalu ated through comparison of the parameter estimates presented in Table 1 . The estimation of the trans port parameter is relatively stable, with COVs gen erally ranging from 10 to 15% across regions for all model configurations. However, there was 10-20% difference in K 1 between the two-and three- Reported are mean and percentage coefficient of variation (% COY) for parameter estimates from least-squares fits of region of-interest data and pixel-by-pixel estimations via a weighted integral method. Yalues for Klare given in ml g -I min -I , for DY" in mI g-I .
compartment approaches, indicating that a bias in the transport estimate occurs when using the sim plified model. This is most likely attributable to the noninstantaneous equilibration between compart ments that is assumed in the model simplifications.
The degree of variability in absolute K I values seen with [ II C]FMZ is as good as or better than that with other PET procedures, including those using [ 1 8 F]fluorodeoxyglucose, [ 1 5 0]H20, or different re ceptor ligands. The variability in the estimates of the receptor-related parameters is far more depen dent upon the model configuration employed. In the two-compartment model, the total tissue distribu-FIG. 6. Relation between the estimate of DV" (ml g -1 ; from a pixel-by-pixel weig hted i nteg ral ap proach using a two-parameter model configura tion) and Bmax'IKd (k3Ik4); from least-squares es timation using a three-parameter model config uration across all regions of interest analyzed.
The correlation coefficient across all subjects and the coefficients from linear regression are given in the lower right. The slope and intercept give the free and the free plus nonspecific ligand distribution volumes, respectively, as de scribed by Eq. 5. Correlations across regions within each subject are given in the upper left.
DV" 8 6 4 2 tion volume (DY') is assumed to be dominated by specific binding. As described in Eq. 5, DY' is lin early related to the ratio Bmax'IKd• This ratio can then be obtained by assuming or estimating values for the free and nonspecific distribution volumes. For the three-and four-parameter models, the esti mates of k3' (konBmax'), or the ratio k31k4 (Bmax'IKd) provide the information related to receptor density. As model complexity increases, the variability in the estimates of the receptor-related parameter is seen to increase, with COYs typically ranging from 9-12% for DV" in the two-parameter configuration to 20-50% for k3 in the three-parameter configura- tion and to 5� 100% for k3 in the four-parameter configuration. The COVs for k31k4 are smaller, rang ing from 12-25% for the three-parameter configura tion to 2�80% for the four-parameter configura tion.
Examination of the goodness of fit (X 2 ) for differ ent models reveals that a four-parameter configura tion was not statistically better in most regions than a three-parameter configuration (F test). For two parameter estimations, the best fits (lowest X 2 val ues) were obtained in regions that have the highest receptor densities, such the cerebral cortex. The poorest fits were obtained in the regions with lowest receptor densities, such as the pons. This is predict able considering that the two-compartment model assumes that free and specifically bound tissue compartments equilibrate rapidly with respect to the duration of the individual PET scans and blood brain barrier transport rates. Regions with high re ceptor densities will equilibrate more rapidly than those with low receptor densities and should be bet ter fit by a two-compartment model. Goodness of fit improved most for regions with the lowest receptor densities and improved least for regions with the highest receptor densities when expanding from a two-compartment to a three-compartment model configuration.
Analysis of the temporal duration of data re quired to estimate ligand delivery (Fig. 4) shows that two-parameter model estimates (mean value and variance) become stable with as little 2�30 min of data. Earlier than this time, positive biases (over estimations) and slight increases in the variance of K\ are seen. The bias if probably caused in part by the finite time required for equilibration to occur between the tissue compartments when the model assumes instantaneous equilibration. The biases are somewhat greater in the pons, most likely owing to the longer equilibration times and hence the poorer quality fits seen in that region. The three-parameter model provides nearly as stable an estimate of de livery, although as the scan duration is reduced, the variance in K\ increases to a greater extent than with the two-parameter model. However, there is not the same trend toward K\ overestimation, pre sumably owing to the improved goodness of fit.
The temporal range of data is more crucial for estimating the receptor-related parameters. Figure  5 (top) shows that estimating DV" using the two compartment approach also requires only 2�30 min of data. When fewer data are used, the bias and variance in DV" increase more rapidly than they did in K\. The bias is negative, opposite of that ob served in K\, and again is presumably due in part to the finite equilibration times of the tissue com part-J Cereb Blood Flow Me/ab, Vol. 11, No.5, 1991 ments. Figure 5 (center and bottom) demonstrates the increased variance in the receptor-related pa rameter when a three-instead of a two-compart ment model is employed. At least 60 min of data is required to yield stable results, and estimates are still more variable than the estimate of DV". As fewer data are included, both k3 and k4 estimates begin to vary widely, indicating that these two pa rameters are not uniquely identifiable. This is caused by equilibration occurring too rapidly to separate kinetically the bound and free ligand com partments with much certainty. Only the ratio of the two parameters, k31k4' is relatively stable.
As a four-parameter model configuration was not able to provide stable receptor estimates, and since it was not found to provide statistically better fits than a three-parameter model, this option was dis carded. A three-parameter model was found to pro vide reasonably precise estimates of the ratio k31k4 (COVs of 12-25%), but not k3 alone (COVs of 2�50%). Thus, the two alternatives for estimation of BZR density from a single injection of [\\C]FMZ are a calculation of the "binding potential", Bmax'IKd (kik4), from a three-compartment, three parameter implementation or an estimation of DV" from the simplified two-compartment, two parameter approach. The advantages of the Bmax'IKd approach are that the goodness of fit is somewhat better when a three-compartment model is employed, particularly for regions of low receptor density, and that Bmax' I Kd provides a more direct estimate of receptor density than does DV'. How ever, advantages of the DV' approach are that the COVs in the estimates of the receptor-related pa rameter were smaller for all regions examined, that the calculations are simpler and faster, that func tional images of the model parameters are more eas ily obtained, and that a shorter data acquisition pro tocol can be implemented. Furthermore, the overall correlation between the estimates of Bmax' I Kd and DV' was 0.954 (Fig. 6) . Additional studies validat ing that the simplified model can differentiate be tween ligand delivery and binding processes in the human brain are reported separately (see Holthoff et aI., 199 1) .
The comparison of least-squares fitting of tracer activity in large ROIs and pixel-by-pixel weighted integral estimation, presented in Table 2 , reveals systematic differences in both K\ and DV'. Esti mates using the pixel-by-pixel approach tend to be slightly higher for K1 (+ 3-5%) and slightly lower for DV" ( -3-6%). This is due in part to CBV effects persisting after 30 s post injection, since the pixel by-pixel approach did not correct for CBV effects (other than excluding the first 30 s of data from the fits), whereas the ROI approach utilized corrections for both CBV and time shift. This was particularly evident in the pons where pixel-by-pixel results av eraged 12% higher for K l and 7% lower for DV". These differences were consistent across subjects, as shown by the high correlations between the two techniques. Correlation coefficients ranged from 0.95 to >0.99 for both K l and DV' in all regions, except the pons, where correlations were only 0.81 and 0.85 for K l and DV", respectively. The results in the pons may reflect that the regional data here were most poorly fit and thus more susceptible to differences in the parameter estimation methods.
The simplified two-parameter pixel-by-pixel weighted integral approach was subsequently ap plied to data from the additional 12 subjects, with the results also reported in Table 2 . The data from the second group yield similar parameter values and COY s for K 1 and D V" to those of the initial group of six subjects. Thus, across the entire group of 18 young normal controls, a two-compartment, two parameter model is seen to consistently produce stable estimates of both ligand delivery and distri bution, with COY s for both parameters ranging from 7 to 15% across regions. This degree of preci sion, which is as good as or better than can be ob tained with other PET tracers, is noteworthy since accurate determination of the fraction of labeled metabolites in the plasma is essential for accurate estimation of D V", and the fraction is large for FMZ.
The relationship between the estimates of Bmax'/Kct from the three-parameter analysis and D V" from the two-parameter pixel-by-pixel analy sis, shown in Fig. 6 , demonstrates several points. The overall correlation across the six subjects was >0.95, indicating a strong relation between the two parameters and, as pointed out above, provides ev idence that D V" is an appropriate parameter for as sessing receptor density. The correlations across all regions within a single subject are even higher (r > 0.99). The variation in the estimates of free and non specific distribution volumes from subject to sub ject accounts for the lower correlation across sub jects. In the plot of DV", Bmax' Kct, however, it is seen that the slope is not equal to one and the y intercept not equal to zero. This is predicted by Eq. 5, which describes DV" as a linear function of Bmax'/Kct, having a slope of DVp (the distribution volume of free ligand) and an intercept of D V p + NS (the free plus nonspecific distribution volume). Lin ear regression across all subjects and regions yields values of 0.77 ml g-l for DVp and 0.94 ml g-l for D VF+NS' It is important to point out that the ability to derive receptor binding information from DV' of [llC]FMZ studies is due largely to the tracer's high rate of specific binding and low level of nonspecific binding. Other potential receptor agents with lower rates of specific binding and/or higher fractions of nonspecific binding, such as e 8 F]GBR 12909, (Koeppe et aI., 1990) , would perform much more poorly with this type of analysis.
The results presented here are in close agreement with those from several multiple injection tech niques reported previously. Our Bmax' / Kct ratios in cortex of � 5 compare with 6-8 for Blomqvist and co-workers (1990) . They performed estimates using both kinetic and equilibrium approaches on a single individual. We note in their Table 1 that the kinet ically determined value for Bmax' / Kct in cortex is 5.7, fairly close to our value. However, their estimate using the equilibrium method yielded a value on.8, or 36% higher than their kinetic value. This is most likely because their study was not performed under conditions of true equilibrium (Carson et al., 1989) . Simulations using our measured input functions predict that Bmax'/Kct is overestimated by 25-50% following bolus injection of FMZ, since only pseudo-equilibrium is achieved. Persson et al. (1989) , also using an equilibrium technique, report results for five normal subjects yielding Bmax' /Kct estimates in cortex of 11.7 ± 4.8. Again, this quan tity is overestimated since true equilibrium is never achieved. In addition, their COY is >40%, and far exceeds our values of 10-15%. From a single equi librium experiment involving five subjects, Pappata and co-workers (1988) report Bmax' /Kct values of 6.11 and 5.45 for occipital and frontal cortex, re spectively. These values correspond closely to our values of 5.30 and 4.62, with the differences once again being attributable to the lack of achieving true equilibrium with their approach. Finally, Price et al. (1990) , using a kinetic approach, report k3/k4 [(Bmax'/Kct)/(l + k5/k6)] values in occipital cortex and thalamus of 4.2 and 1.3, respectively, also agreeing quite well with our values of 4.0 and 1.6.
In conclusion, we have evaluated two-, three-, and four-parameter model configurations for kinetic analysis of the central benzodiazepine antagonist e lC]FMZ following a single high specific activity administration. The four-parameter configuration was determined to be unsuitable owing to high vari ances in the parameter estimates. Either a three parameter model estimation of Bmax' /Kct (k3/k4)' us ing the free and nonspecific distribution volumes estimated from the pons, or a two-parameter esti mate of D V" as found to provide reliable measures of receptor density, assuming that the use of the pons as a reference region for free plus nonspecific binding is valid and that there are no substantial regional changes in the ligand equilibrium binding constant (Kd). The two-parameter model configura tion was selected as marginally superior since it re quires only � 30 min of data collection, is easy to implement, and yields functional images, yet still can provide independent assessment of both ligand delivery and receptor binding. However, in severe disease cases, when the free + nonspecific compo nent constitutes a greater fraction of D V", it may be important to retrospectively analyze affected re gions with a three-parameter model, estimating Bmax'IKd directly in addition to DV".
